Evaluation of the sexual performance in male drug abusers under treatment with methadone and buprenorphine in 2021
Background: Sexual dysfunction is a common complication of methadone maintenance therapy (MMT) and buprenorphine maintenance therapy (BMT). The aim of this study was to evaluate of sexual function in addicted men under treatment with methadone and buprenorphine. Materials and Methods: In this cross...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | fas |
Published: |
Kashan University of Medical Sciences and Health Services
2023-01-01
|
Series: | Fiyz̤ |
Subjects: | |
Online Access: | http://feyz.kaums.ac.ir/article-1-4711-en.html |
_version_ | 1797835557895667712 |
---|---|
author | Afshin Ahmadvand Motahhareh Mansournejad Zahra Sepehrmanesh |
author_facet | Afshin Ahmadvand Motahhareh Mansournejad Zahra Sepehrmanesh |
author_sort | Afshin Ahmadvand |
collection | DOAJ |
description | Background: Sexual dysfunction is a common complication of methadone maintenance therapy (MMT) and buprenorphine maintenance therapy (BMT). The aim of this study was to evaluate of sexual function in addicted men under treatment with methadone and buprenorphine.
Materials and Methods: In this cross-sectional study, 30 men undergoing methadone maintenance treatment (n=15) and buprenorphine (n=15) were included in the study in Kashan addiction treatment centers. The Golombok-Rust Inventory of Sexual Satisfaction (GRISS) questionnaire was used to collect data. The collected data were analyzed using SPSS version 22 software and using Fisher's exact tests, independent t test and linear regression.
Results: There was no significant difference in the mean total score of sexual performance between the methadone (38.40±13.58) and buprenorphine (38.33±14.56) groups (P=0.733).
Conclusion: The results showed that in both groups, sexual performance was at an unfavorable level, and therefore, it is recommended that future studies focus on providing strategies to improve sexual performance and satisfaction in patients undergoing maintenance treatment with methadone and buprenorphine. |
first_indexed | 2024-04-09T14:55:35Z |
format | Article |
id | doaj.art-9ff1e3a9f714474a960c8e05eac97c01 |
institution | Directory Open Access Journal |
issn | 1029-7855 2008-9821 |
language | fas |
last_indexed | 2024-04-09T14:55:35Z |
publishDate | 2023-01-01 |
publisher | Kashan University of Medical Sciences and Health Services |
record_format | Article |
series | Fiyz̤ |
spelling | doaj.art-9ff1e3a9f714474a960c8e05eac97c012023-05-02T07:26:38ZfasKashan University of Medical Sciences and Health ServicesFiyz̤1029-78552008-98212023-01-01271840846Evaluation of the sexual performance in male drug abusers under treatment with methadone and buprenorphine in 2021Afshin Ahmadvand 0Motahhareh Mansournejad 1Zahra Sepehrmanesh2- Clinical Research Development Unit Matini /Kargarnejad Hospitals, Kashan University of Medical Sciences, Kashan, I.R. Iran.Student Research Committee, Kashan University of Medical Sciences, Kashan, I.R. Iran.- Clinical Research Development Unit Matini /Kargarnejad Hospitals, Kashan University of Medical Sciences, Kashan, I.R. Iran.Background: Sexual dysfunction is a common complication of methadone maintenance therapy (MMT) and buprenorphine maintenance therapy (BMT). The aim of this study was to evaluate of sexual function in addicted men under treatment with methadone and buprenorphine. Materials and Methods: In this cross-sectional study, 30 men undergoing methadone maintenance treatment (n=15) and buprenorphine (n=15) were included in the study in Kashan addiction treatment centers. The Golombok-Rust Inventory of Sexual Satisfaction (GRISS) questionnaire was used to collect data. The collected data were analyzed using SPSS version 22 software and using Fisher's exact tests, independent t test and linear regression. Results: There was no significant difference in the mean total score of sexual performance between the methadone (38.40±13.58) and buprenorphine (38.33±14.56) groups (P=0.733). Conclusion: The results showed that in both groups, sexual performance was at an unfavorable level, and therefore, it is recommended that future studies focus on providing strategies to improve sexual performance and satisfaction in patients undergoing maintenance treatment with methadone and buprenorphine.http://feyz.kaums.ac.ir/article-1-4711-en.htmladdictionsexual dysfunctionmethadone maintenance therapy (mmt)buprenorphine maintenance therapy (bmt) |
spellingShingle | Afshin Ahmadvand Motahhareh Mansournejad Zahra Sepehrmanesh Evaluation of the sexual performance in male drug abusers under treatment with methadone and buprenorphine in 2021 Fiyz̤ addiction sexual dysfunction methadone maintenance therapy (mmt) buprenorphine maintenance therapy (bmt) |
title | Evaluation of the sexual performance in male drug abusers under treatment with methadone and buprenorphine in 2021 |
title_full | Evaluation of the sexual performance in male drug abusers under treatment with methadone and buprenorphine in 2021 |
title_fullStr | Evaluation of the sexual performance in male drug abusers under treatment with methadone and buprenorphine in 2021 |
title_full_unstemmed | Evaluation of the sexual performance in male drug abusers under treatment with methadone and buprenorphine in 2021 |
title_short | Evaluation of the sexual performance in male drug abusers under treatment with methadone and buprenorphine in 2021 |
title_sort | evaluation of the sexual performance in male drug abusers under treatment with methadone and buprenorphine in 2021 |
topic | addiction sexual dysfunction methadone maintenance therapy (mmt) buprenorphine maintenance therapy (bmt) |
url | http://feyz.kaums.ac.ir/article-1-4711-en.html |
work_keys_str_mv | AT afshinahmadvand evaluationofthesexualperformanceinmaledrugabusersundertreatmentwithmethadoneandbuprenorphinein2021 AT motahharehmansournejad evaluationofthesexualperformanceinmaledrugabusersundertreatmentwithmethadoneandbuprenorphinein2021 AT zahrasepehrmanesh evaluationofthesexualperformanceinmaledrugabusersundertreatmentwithmethadoneandbuprenorphinein2021 |